Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts
暂无分享,去创建一个
[1] K. Frei,et al. Tumor Necrosis Factor (cid:2) and Lymphotoxin (cid:2) Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis , 2002 .
[2] G. Nolan,et al. Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis , 1997, The Journal of experimental medicine.
[3] L. Steinman,et al. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. , 1997, International immunology.
[4] R. W. Davis,et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Sobel,et al. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.
[6] Susumu Tonegawa,et al. Synaptic plasticity, place cells and spatial memory: study with second generation knockouts , 1997, Trends in Neurosciences.
[7] H. Lassmann,et al. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview , 1997, Journal of Neuroimmunology.
[8] T. Owens,et al. Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.
[9] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[10] L. Steinman. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] U. Utz,et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein , 1996, Nature.
[12] L. Steinman,et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.
[13] G. Kollias,et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] L. Steinman,et al. Administration of Neutralizing Antibodies to Interleukin-6 (IL-6) Reduces Experimental Autoimmune Encephalomyelitis and Is Associated with Elevated Levels of IL-6 Bioactivity in Central Nervous System and Circulation , 1995, Molecular medicine.
[15] L. Santambrogio,et al. Staphylococcal enterotoxin B and tumor‐necrosis factor‐α‐induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor‐β and interleukin‐10 , 1995, European journal of immunology.
[16] T. Olsson,et al. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β , 1995, Journal of Neuroimmunology.
[17] R. Davis,et al. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Fontana,et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis , 1995, Nature Medicine.
[19] K. Selmaj,et al. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I , 1995, Journal of Neuroimmunology.
[20] C. Piccirillo,et al. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. , 1995, Journal of immunology.
[21] W. Cowden,et al. Cytokines and Murine Autoimmune Encephalomyelitis: Inhibition or Enhancement of Disease with Antibodies to Select Cytokines, or by Delivery of Exogenous Cytokines Using a Recombinant Vaccinia Virus System , 1995, Scandinavian journal of immunology.
[22] D. Mitchell,et al. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production , 1994, The Journal of experimental medicine.
[23] D. Hanley,et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.
[24] L. Steinman,et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.
[25] Y. Qin,et al. Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats. , 1993, Journal of autoimmunity.
[26] A. Cross,et al. Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.
[27] Y. Shimamoto,et al. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats , 1991, Journal of Neuroimmunology.
[28] M. Sharief,et al. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .
[29] D. Baker,et al. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. , 1991, Cellular immunology.
[30] E. Benveniste,et al. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.
[31] R. Clark,et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.
[32] Moses Rodriguez,et al. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. , 1990, International immunology.
[33] D. Mitchell,et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. , 1990, International immunology.
[34] K. Selmaj,et al. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.
[35] R. Zinkernagel,et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice , 1996 .